Cyclin M3 Antibody [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-32134PCP
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Cyclin M3 Antibody [PerCP]
Immunogen
The immunogen this antibody was made to, maps to a region between residue 657 to 707 of human Cyclin M3 using the numbering given in entry NP_060093.3 (GeneID 26505).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for Cyclin M3 Antibody [PerCP]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Cyclin M3
Alternate Names
ACDP3cyclin-M3, ancient conserved domain protein 3, Ancient conserved domain-containing protein 3, cyclin M3, Cyclin-M3, DKFZp434I1016, FLJ20018, metal transporter CNNM3
Gene Symbol
CNNM3
Additional Cyclin M3 Products
Product Documents for Cyclin M3 Antibody [PerCP]
Product Specific Notices for Cyclin M3 Antibody [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...